-
Income Statement
-
Balance Sheet
-
Cashflow Statement
-
Profitability
-
Ratios
GE HealthCare Technologies's Income Statement
| Chart | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Revenue |
|
$17.59 B | $18.34 B | $19.55 B | $19.67 B | $20.63 B |
| Cost of Revenue |
|
$10.41 B | $11.16 B | $11.63 B | $11.47 B | $12.38 B |
| Gross Profit |
|
$7.17 B | $7.18 B | $7.92 B | $8.21 B | $8.25 B |
| Research & Development |
|
$816.00 M | $1.03 B | $1.21 B | $1.31 B | $1.26 B |
| Selling,General & Administrative |
|
$3.56 B | $3.63 B | $4.28 B | $4.27 B | $4.23 B |
| Operating Expense |
|
$4.38 B | $4.66 B | $5.49 B | $5.58 B | $5.49 B |
| Operating Income |
|
$2.80 B | $2.52 B | $2.44 B | $2.63 B | $2.76 B |
| Net Income |
|
$2.25 B | $1.92 B | $1.57 B | $1.99 B | $2.08 B |
GE HealthCare Technologies's Balance Sheet
| Chart | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Cash and Cash Equivalents |
|
$556.00 M | $1.45 B | $2.50 B | $2.89 B | $4.51 B |
| Inventories |
|
$1.95 B | $2.16 B | $1.96 B | $1.94 B | $2.23 B |
| Total Current Assets |
|
$6.54 B | $7.82 B | $9.01 B | $9.52 B | $10.70 B |
| Property,Plant and Equipment |
|
$2.24 B | $2.31 B | $2.50 B | $2.55 B | $3.09 B |
| Goodwill |
|
$12.89 B | $12.81 B | $12.94 B | $13.14 B | $13.49 B |
| Total Assets |
|
$26.31 B | $27.54 B | $32.45 B | $33.09 B | $36.91 B |
| Total Liabilities |
|
$9.41 B | $17.95 B | $25.14 B | $24.44 B | $26.31 B |
| Retained Earnings |
|
- | - | $1.33 B | $3.26 B | $5.28 B |
| Total Shareholder Equity |
|
$16.66 B | $9.36 B | $7.13 B | $8.45 B | $10.38 B |
| Common Stock |
|
- | - | $5.00 M | $5.00 M | $5.00 M |
GE HealthCare Technologies's Cash flow
| Chart | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Depreciation & Amortization |
|
$625.00 M | $633.00 M | $610.00 M | $580.00 M | $578.00 M |
| Dividends Payout |
|
- | - | -$41.00 M | -$55.00 M | -$64.00 M |
| Capital Expenditures (Capex) |
|
-$248.00 M | -$310.00 M | -$387.00 M | -$401.00 M | -$482.00 M |
| Free Cash Flow (FCF) |
|
$1.36 B | $1.80 B | $1.71 B | $1.55 B | $1.51 B |
GE HealthCare Technologies's Profitability
| Chart | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Gross Profit |
|
$7.17 B | $7.18 B | $7.92 B | $8.21 B | $8.25 B |
| Gross Profit Margin (%) |
|
40.80% | 39.14% | 40.52% | 41.71% | 39.99% |
| Operating Income |
|
$2.80 B | $2.52 B | $2.44 B | $2.63 B | $2.76 B |
| Operating Income Margin (%) |
|
15.89% | 13.75% | 12.45% | 13.34% | 13.39% |
| Net Income |
|
$2.25 B | $1.92 B | $1.57 B | $1.99 B | $2.08 B |
| Net Income Margin (%) |
|
12.78% | 10.45% | 8.02% | 10.13% | 10.10% |
| EBITDA |
|
$3.54 B | $3.17 B | $3.51 B | $3.67 B | $3.79 B |
| EBITDA Margin (%) |
|
20.13% | 17.26% | 17.97% | 18.64% | 18.35% |
GE HealthCare Technologies's Ratios
| Chart | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) |
|
13.49% | 20.48% | 21.98% | 23.59% | 16.19% |
| Return on Assets (ROA) |
|
8.54% | 6.96% | 4.83% | 6.02% | 4.55% |
| Debt to Equity |
|
2.62% | 92.28% | 138.27% | 111.00% | 96.38% |
| Debt to total asset |
|
1.66% | 31.36% | 30.39% | 28.34% | 27.10% |
| Enterprise value to revenue |
|
1.54 | 1.84 | 2.18 | 2.14 | 1.71 |
| Enterprise value to EBITDA |
|
7.67 | 10.64 | 12.11 | 11.49 | 9.34 |
| Enterprise value |
|
$27.16 B | $33.69 B | $42.54 B | $42.14 B | $33.44 B |
| Tax Rate (%) |
|
20.87% | 22.41% | 31.47% | 20.57% | 22.18% |
Frequently Asked Questions
